SAN DIEGO, March 16 /PRNewswire/ -- The Strategic Research Institute, LLC announced today that final preparations for the inaugural Innate Immunity World Congress are complete. The meeting, scheduled for March 20-22nd in San Diego, has gathered together world experts in innate immune modulation. Industry and academic leaders will present the state of the art and prospects for exploiting this rapidly moving field for improved cancer, infectious disease, allergy and asthma therapies as well as targeting innate immune mechanisms with novel vaccine adjuvants.
Presenting companies and institutions for the congress include: * 3M Pharmaceuticals * Beckman Research Institute at the City of Hope * Chiron Corporation * Cerus Corporation * Coley Pharmaceuticals * Dynavax Technologies * Eli Lilly * Emory University * Globe Immune * Idera Pharmaceuticals * Inimex Pharmaceuticals * Istituto Nazionale Tumori * NIAID, NIH * Novartis * Roche Pharmaceuticals * University of California, San Diego School of Medicine * University of Pittsburgh Cancer Institute * University of Texas Medical Branch * Vaxinnate Corporation * Yale University School of Medicine
To receive the full agenda in PDF, please contact Seth Fritts of Strategic Research Institute at sfritts@srinstitute.com or 212-967-0095, x256. You can also view the agenda and speakers on the web at: http://www.srinstitute.com/innate.
Leverage our strong position in the pharmaceutical sector to showcase your products and services to this high-level, targeted audience of pharmaceutical scientists and executive decision makers. To inquire about sponsorship & exhibition opportunities, please contact Don Buford at 212-967-0095 x277 or dbuford@srinstitute.com.
Strategic Research Institute, LLC
CONTACT: Seth Fritts of Strategic Research Institute, +1-212-967-0095,ext. 256, sfritts@srinstitute.com
